Comparison of Staples Versus Prolene Suture for Skin Closure at Cesarean Delivery

November 1, 2018 updated by: Natali Aziz, Stanford University

Comparison of Staples Versus Nonabsorbable Subcuticular (Prolene) Suture for Skin Closure in Cesarean Deliveries: A Randomized Study

Currently different materials are used to close the skin after a cesarean delivery, including absorbable suture, non-absorbable suture and staples. It is not known what is the best choice of material to close the skin after a cesarean section, but commonly staples or dissolvable suture is used. Recently plastic surgeons have found that non-dissolvable suture may have a better cosmetic outcome than staples. The investigators hope to learn if there is a difference in pain both at suture/staple removal and 6 weeks postoperatively between Prolene suture, Absorbable suture (monocryl or vicryl) or staples. The investigators also plan to look for differences in wound complications and patient satisfaction, as well as operating and removal times. This knowledge will be important in helping practitioners choose the closure technique at cesarean delivery.

Study Overview

Detailed Description

Patients who meet inclusion criteria will be approached upon admission to Labor and Delivery. A study staff member will describe the study and offer participation. If a patient agrees to participate, she will sign research protocol and HIPAA consent forms and receive a copy of these forms. The patient's chart will be flagged, indicating that she is a study participant. The patient's prenatal care and labor and delivery will be managed by her physician per standard of care at the physician's discretion, including routine surgical preparation and procedures.

When a participating patient is scheduled for a cesarean section, she will be randomized to Arm 1 (Staples) or Arm 2 (Prolene) or Arm 3 (Monocryl or Vicryl absorbable suture). She will be treated as per standard of care and her cesarean section performed per physician discretion. After the closure of the fascial layer, the surgeons will follow the same protocol for each study participant, including wound irrigation with warm sterile saline and reapproximation of the subcutaneous layer if greater than 2.0 cm in depth (per standard of care). The patient in Arm 1 will have skin closure with staples. The patient in Arm 2 will have skin closure with 2-0 Prolene in a subcuticular fashion. The patient in Arm 3 will have skin closure with monocryl or vicryl in the standard fashion. Patients in Arms 1 and 2 will have their closure material removed at the physician's discretion per the standard of care at post-operative day 3 or 4.

Pain level will be assessed on the first and third or fourth day after surgery and again at six weeks.

Study Type

Interventional

Enrollment (Actual)

15

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • California
      • Palo Alto, California, United States, 94304
        • Lucile Packard Childrens Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 55 years (ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Pregnant women undergoing primary or repeat cesarean section
  • Maternal age greater than or equal to 18 years of age
  • Gestational age greater than or equal to 34 weeks
  • Elective and non-elective cesarean section

Exclusion Criteria:

  • Type 1 or Type 2 diabetes
  • BMI greater than 35
  • Pre-operative diagnosis of chorioamnionitis
  • History of drug or alcohol abuse
  • Contraindication to NSAIDs
  • Chronic pain diagnosis
  • Narcotic use prior to pregnancy
  • Maternal age less than 18 years of age
  • General anesthesia
  • Chorioamnionitis, clinical suspicion of chorioamnionitis, or risk factors for chorioamnionitis (membrane rupture greater than 18 hours, GBS positive status)
  • Vertical skin incision

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
ACTIVE_COMPARATOR: Staples
Use of staples for skin closure at cesarean section
Staples for closure of cesarean section skin incision
Other Names:
  • Reflex one skin stapler 35 wide. Manufactured by Conmed
ACTIVE_COMPARATOR: Prolene non-absorbable sutures
Use of Prolene non-absorbable sutures for skin closure at cesarean section
Prolene non-absorbable sutures for closure of cesarean skin incision
Other Names:
  • Prolene 2-0 18 inch on FS needle. Manufactured by Ethicon
ACTIVE_COMPARATOR: Absorbable sutures
Use of absorbable sutures for skin closure at cesarean section; monocryl or vicryl.
Absorbable sutures for closure of cesarean skin incision
Other Names:
  • Monocryl or Vicryl. Manufactured by Ethicon

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Level of Pain on a Scale During the Post-operative Hospitalization Period
Time Frame: Post-operative day 3 or 4.
Pain level on a Mosby visual analog pain scale of 1 (no pain) to 10 (worst pain)
Post-operative day 3 or 4.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Level of Pain on a Scale at 6 Weeks Postpartum
Time Frame: Post-operative week 6
Pain level on a scale (Mosby visual analog pain scale) of 1 (no pain) to 10 (worst pain).
Post-operative week 6
Count of Participants With Wound Complications
Time Frame: Post-operative week 6
Wound complications include conditions like infection, seroma/hematoma and dehiscence
Post-operative week 6
Level of Patient Satisfaction to the Wound Appearance
Time Frame: Post-operative day 3 or 4
Level of patient satisfaction measured on a scale of 1 (very unsatisfied) to 10 (very satisfied)
Post-operative day 3 or 4
Level of Patient Satisfaction to the Wound Appearance at 6 Weeks Postpartum
Time Frame: Post-operative week 6
Level of patient satisfaction measured on a scale of 1 (very unsatisfied) to 10 (very satisfied)
Post-operative week 6
Time From Skin Incision to the Skin Closure
Time Frame: Day of cesarean delivery (up to 8 hours)
Measured in minutes
Day of cesarean delivery (up to 8 hours)
Time Needed for the Suture Removal
Time Frame: Post-operative day 3 or 4
Measured in seconds
Post-operative day 3 or 4
Level of Patient's Satisfaction to the Cosmesis of the Wound
Time Frame: Post-operative week 6
Measured on a scale of 0 (very unsatisfied to the cosmesis) to 10 (very satisfied to the cosmesis)
Post-operative week 6
Level of Patient's Overall Patient Satisfaction to the Type of Closure
Time Frame: Post-operative day 1
Level of patient satisfaction measured on a scale of 1 (very unsatisfied) to 10 (very satisfied)
Post-operative day 1
Level of Patient's Overall Patient Satisfaction to the Type of Closure
Time Frame: Post-operative day 3 or 4
Level of patient satisfaction measured on a scale of 1 (very unsatisfied) to 10 (very satisfied)
Post-operative day 3 or 4
Level of Patient's Overall Patient Satisfaction to the Type of Closure
Time Frame: Post-operative week 6
Level of patient satisfaction measured on a scale of 1 (very unsatisfied) to 10 (very satisfied)
Post-operative week 6

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

January 1, 2012

Primary Completion (ACTUAL)

May 4, 2013

Study Completion (ACTUAL)

May 4, 2013

Study Registration Dates

First Submitted

January 5, 2012

First Submitted That Met QC Criteria

January 10, 2012

First Posted (ESTIMATE)

January 13, 2012

Study Record Updates

Last Update Posted (ACTUAL)

March 4, 2019

Last Update Submitted That Met QC Criteria

November 1, 2018

Last Verified

November 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • 22389

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pregnancy

Clinical Trials on Staples

Subscribe